KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,433,048 | -3.0% | 705,378 | +12.5% | 0.00% | 0.0% |
Q2 2023 | $6,632,454 | -14.4% | 626,886 | -1.0% | 0.00% | -50.0% |
Q1 2023 | $7,744,060 | -18.0% | 633,202 | -16.8% | 0.00% | 0.0% |
Q4 2022 | $9,446,914 | +8.6% | 761,234 | +19.5% | 0.00% | 0.0% |
Q3 2022 | $8,698,000 | -25.1% | 636,812 | +0.5% | 0.00% | 0.0% |
Q2 2022 | $11,617,000 | +10.5% | 633,782 | -3.0% | 0.00% | 0.0% |
Q1 2022 | $10,509,000 | +13.6% | 653,548 | -1.1% | 0.00% | 0.0% |
Q4 2021 | $9,252,000 | -34.1% | 660,861 | -11.8% | 0.00% | 0.0% |
Q3 2021 | $14,039,000 | -12.0% | 749,534 | -2.0% | 0.00% | -33.3% |
Q2 2021 | $15,954,000 | -21.2% | 765,179 | +6.8% | 0.00% | -25.0% |
Q1 2021 | $20,253,000 | -17.5% | 716,413 | -4.6% | 0.00% | -20.0% |
Q4 2020 | $24,536,000 | +18.4% | 751,263 | +11.1% | 0.01% | 0.0% |
Q3 2020 | $20,719,000 | +81.3% | 676,175 | -3.5% | 0.01% | +66.7% |
Q2 2020 | $11,425,000 | +151.5% | 700,917 | +53.5% | 0.00% | +200.0% |
Q1 2020 | $4,543,000 | -23.7% | 456,615 | +5.5% | 0.00% | 0.0% |
Q4 2019 | $5,953,000 | -15.7% | 432,980 | -7.0% | 0.00% | -50.0% |
Q3 2019 | $7,063,000 | -7.0% | 465,615 | +20.8% | 0.00% | 0.0% |
Q2 2019 | $7,591,000 | +21.0% | 385,478 | +1.9% | 0.00% | 0.0% |
Q1 2019 | $6,275,000 | +19.1% | 378,229 | +0.8% | 0.00% | +100.0% |
Q4 2018 | $5,269,000 | -20.2% | 375,255 | -0.5% | 0.00% | -50.0% |
Q3 2018 | $6,603,000 | +13.6% | 377,317 | +18.1% | 0.00% | +100.0% |
Q2 2018 | $5,813,000 | +21.3% | 319,420 | +25.0% | 0.00% | 0.0% |
Q1 2018 | $4,791,000 | +33.5% | 255,508 | +8.9% | 0.00% | 0.0% |
Q4 2017 | $3,589,000 | +14.4% | 234,547 | +11.8% | 0.00% | 0.0% |
Q3 2017 | $3,137,000 | +128.6% | 209,879 | +42.3% | 0.00% | – |
Q2 2017 | $1,372,000 | +997.6% | 147,483 | +939.3% | 0.00% | – |
Q1 2017 | $125,000 | +71.2% | 14,190 | +14.6% | 0.00% | – |
Q4 2016 | $73,000 | +7.4% | 12,382 | +13.7% | 0.00% | – |
Q3 2016 | $68,000 | – | 10,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |